NCT07423234

Brief Summary

The goal of this clinical trial is to understand whether a simple education and self-management program with home exercises can reduce pain and improve daily function in adults with long-lasting jaw pain caused by temporomandibular disorders (TMD) as much as a more intensive hands-on physiotherapy approach. The main questions it aims to answer are:

  1. 1.Does an education and self-management exercise program reduce jaw pain, improve jaw function and reduce how much pain interferes with daily activities?
  2. 2.Does this program improve outcomes similarly to the usual treatment for TMDs, which includes also manual therapy and supervised exercise sessions?
  3. 3.A group receiving two physiotherapy-supervised education and self-management sessions with personalized home exercises; or
  4. 4.A group receiving six physiotherapy usual treatment sessions, which may include education, exercises, and hands-on therapy;

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jan 2026Aug 2026

First Submitted

Initial submission to the registry

January 15, 2026

Completed
1 day until next milestone

Study Start

First participant enrolled

January 16, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 20, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2026

Expected
Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

5 months

First QC Date

January 15, 2026

Last Update Submit

February 17, 2026

Conditions

Keywords

Temporomandibular DisordersPatient educationSelf-managementChronic painRandomized controlled trialPain management

Outcome Measures

Primary Outcomes (2)

  • Characteristic Pain Intensity (CPI)

    Graded Chronic Pain Scale (version 2.0). This scale measures two subscales : the Characteristic Pain Intensity (CPI) and the Pain Interference. CPI is used to quantify a patient's jaw and face pain experience by averaging three scores from the past 6 months: current pain, average pain, and worst pain, on a 0-10 scale. The final score ranges from 0 to 100, with higher scores indicating more pain.

    From enrollement to the last evaluation (at 16 weeks after the first treatment)

  • Pain Interference

    Pain Interference (subscale of the GCPS 2.0) is assessed by measuring how pain restricts daily, social, family, and work activities over the past 30 days, using a 0-10 scale. The final score ranges from 0 to 100, with higher scores indicating greater pain interference.

    From enrollement to the last evaluation (at 16 weeks after the first treatment)

Secondary Outcomes (8)

  • Jaw function

    From enrollement to last evaluation (at 16 weeks after the first treatment)

  • Body Pain

    From enrollment to last evaluation (at 16 weeks after the first treatment)

  • Neck disability

    From enrollment to last evaluation (at 16 weeks after the first treatment)

  • Jaw mobility

    From enrollment to last evaluation (at 16 weeks after the first treatment)

  • Catastrophizing

    From enrollment to last evaluation (at 16 weeks after the first treatment)

  • +3 more secondary outcomes

Other Outcomes (2)

  • Central sensitization

    From enrollment to last evaluation (at 16 weeks after the first treatment)

  • Central sensitization

    From enrollment to last evaluation (at 16 weeks after the first treatment)

Study Arms (2)

Patient education and self-management

EXPERIMENTAL

Each of the two sessions will be conducted individually with one of two physiotherapists and will last 45 minutes each. The first session will be used at baseline to deliver proper insights to the patient regarding normal physiology and their TMD, pain pathophysiology using references and visual aids (i.e. video, biomechanical demonstration on human skeleton model) to facilitate understanding. Depending on clinical presentation and scores to self-administered questionnaires, counseling and recommendations will be tailored. Lastly, an exercise program, including self-relief manual techniques and rehabilitation exercises for posture, mobility and strength of the neck and jaw will be demonstrated, practiced and prescribed to the participants (up to 5 exercises). At home, each patient will have access to an informational binder featuring the recommendations and prescribed exercise program to ensure patient's capacity to follow the intended program.

Behavioral: Patient education and self-management

Usual treatment

ACTIVE COMPARATOR

This group will be offered six (30 min, 1x/week) in-clinic PT-supervised sessions from one of two experienced physiotherapists over a 5-week period. The usual intervention group will receive personalized care tailored to each participant's presentation with the intention of reducing pain, increasing mobility and strength, and optimizing daily function. Care provided will not be standardized and will include a combination of manual therapy techniques, at-home exercises (up to 5 jointly chosen by PTs and participants) and education regarding potential contributing factors to the presenting TMD. Treatments will not only focus on the TMJ, but may also involve treatment for the neck, head and shoulder griddle based on the physiotherapist's expert clinical reasoning. All therapies will be documented for analysis.

Procedure: Usual treatment (multimodal)

Interventions

This intervention is a structured, patient-centered education and self-management program for adults with painful temporomandibular disorders (TMD). It is delivered one-on-one by a trained physiotherapist and focuses on improving understanding of jaw pain, reducing harmful oral habits, and restoring confident jaw movement. Participants receive individualized education about TMD, pain mechanisms, stress and habit influences, and practical strategies to manage daily activities such as chewing, speaking, posture, and sleep. The program addresses fear of movement and emphasizes safe, gradual jaw use. Each participant is given a personalized home exercise program targeting jaw and neck mobility, coordination, and muscle relaxation. Participants also set personal goals to support long-term self-management.

Patient education and self-management

Usual care consists of a comprehensive physiotherapy program commonly used for adults with temporomandibular disorders (TMD). Treatment is delivered by a trained physiotherapist. Interventions may include hands-on manual therapy to reduce muscle tension, joint mobilizations to restore normal jaw movement, and supervised therapeutic exercises targeting jaw and neck mobility, coordination, and strength. Participants also receive education and advice regarding posture, oral habits, and daily activity modifications. Participants will have prescribed at-home therapeutic exercises (up to 5 jointly chosen by PT and patient). Participants will receive the same written booklet as the education and self-management arm.

Usual treatment

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnostic of painful TMD according to axis 1 of DC/TMD
  • Experiencing rest pain for at least 3 months
  • With a minimum pain intensity of 3 on a 10-point Numeric Pain Rating Scale (NPRS)

You may not qualify if:

  • History of jaw surgery
  • Recent trauma to head or jaw
  • Ongoing dental treatment
  • History of rheumatologic condition
  • Severe psychiatric condition (e.g severe anxiety or severe depression)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Maisonneuve-Rosemont

Montreal, Quebec, H1T2M4, Canada

Location

MeSH Terms

Conditions

Temporomandibular Joint DisordersChronic PainAgnosia

Interventions

Patient Education as TopicSelf-Management

Condition Hierarchy (Ancestors)

Craniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

Health EducationPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Statistician
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Researcher, Ph.D

Study Record Dates

First Submitted

January 15, 2026

First Posted

February 20, 2026

Study Start

January 16, 2026

Primary Completion

June 1, 2026

Study Completion (Estimated)

August 1, 2026

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in publications will be available upon reasonable request to the corresponding author. This includes primary and secondary outcome measures, baseline demographic and clinical characteristics, and study time-point data used for statistical analyses. The full study protocol, data dictionary, and statistical analysis plan will also be available upon request. Data will be shared in a de-identified format and in accordance with ethical approvals and applicable privacy regulations.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
De-identified individual participant data and supporting documents will be available beginning 12 months after publication of the primary study results and will remain available for 5 years following publication.
Access Criteria
Access to de-identified individual participant data and supporting documents will be granted to qualified researchers who submit a reasonable request with a clear research purpose. Requests must be sent to the corresponding author. Shared materials may include de-identified outcome data, baseline characteristics, and supporting study documents (protocol, data dictionary, and statistical analysis plan). Data will be provided in a secure electronic format following approval of the request and in accordance with ethical approvals and applicable privacy regulations.

Locations